Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Focal Segmental Glomerulosclerosis in a Patient with Ambiguous Genitalia: A Diagnostic Dilemma.

Ross OE, Kujubu DA, Sim JJ.

Perm J. 2017;21. doi: 10.7812/TPP/16-092. Epub 2017 Mar 10.

2.

The Genetics of Nephrotic Syndrome.

Rheault MN, Gbadegesin RA.

J Pediatr Genet. 2016 Mar;5(1):15-24. doi: 10.1055/s-0035-1557109. Epub 2015 Aug 13. Review.

3.

Denys-Drash syndrome associated WT1 glutamine 369 mutants have altered sequence-preferences and altered responses to epigenetic modifications.

Hashimoto H, Zhang X, Zheng Y, Wilson GG, Cheng X.

Nucleic Acids Res. 2016 Dec 1;44(21):10165-10176. Epub 2016 Sep 4.

4.

Disorders of sexual differentiation: I. Genetics and pathology.

El-Sherbiny M.

Arab J Urol. 2013 Mar;11(1):19-26. doi: 10.1016/j.aju.2012.11.005. Epub 2013 Jan 10. Review.

5.

Understanding podocytopathy and its relevance to clinical nephrology.

Singh L, Singh G, Dinda AK.

Indian J Nephrol. 2015 Jan-Feb;25(1):1-7. doi: 10.4103/0971-4065.134531. Review.

6.

Familial FSGS.

Pollak MR.

Adv Chronic Kidney Dis. 2014 Sep;21(5):422-5. doi: 10.1053/j.ackd.2014.06.001. Review.

7.

A novel missense mutation of Wilms' Tumor 1 causes autosomal dominant FSGS.

Hall G, Gbadegesin RA, Lavin P, Wu G, Liu Y, Oh EC, Wang L, Spurney RF, Eckel J, Lindsey T, Homstad A, Malone AF, Phelan PJ, Shaw A, Howell DN, Conlon PJ, Katsanis N, Winn MP.

J Am Soc Nephrol. 2015 Apr;26(4):831-43. doi: 10.1681/ASN.2013101053. Epub 2014 Aug 21.

8.

Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing.

Brown EJ, Pollak MR, Barua M.

Kidney Int. 2014 May;85(5):1030-8. doi: 10.1038/ki.2014.48. Epub 2014 Mar 5. Review.

9.

Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury.

Zhou H, Kajiyama H, Tsuji T, Hu X, Leelahavanichkul A, Vento S, Frank R, Kopp JB, Trachtman H, Star RA, Yuen PS.

Am J Physiol Renal Physiol. 2013 Aug 15;305(4):F553-9. doi: 10.1152/ajprenal.00056.2013. Epub 2013 Jun 12.

10.

Transcriptional regulation by the Wilms tumor protein, Wt1, suggests a role of the metalloproteinase Adamts16 in murine genitourinary development.

Jacobi CL, Rudigier LJ, Scholz H, Kirschner KM.

J Biol Chem. 2013 Jun 28;288(26):18811-24. doi: 10.1074/jbc.M113.464644. Epub 2013 May 9. Erratum in: J Biol Chem. 2014 Apr 18;289(16):11566.

11.

Genetic testing in nephrotic syndrome--challenges and opportunities.

Gbadegesin RA, Winn MP, Smoyer WE.

Nat Rev Nephrol. 2013 Mar;9(3):179-84. doi: 10.1038/nrneph.2012.286. Epub 2013 Jan 15. Review.

12.

Diffuse mesangial sclerosis - Report of two cases.

Vankalakunti M, Jha PK, Madraki RM, Siddini V, Babu K, Ballal SH.

Indian J Nephrol. 2012 May;22(3):213-6. doi: 10.4103/0971-4065.98764.

13.

Progress in pathogenesis of proteinuria.

Zhang A, Huang S.

Int J Nephrol. 2012;2012:314251. doi: 10.1155/2012/314251. Epub 2012 May 24.

14.

Out on a LIM: chronic kidney disease, podocyte phenotype and the Wilm's tumor interacting protein (WTIP).

Sedor JR, Madhavan SM, Kim JH, Konieczkowski M.

Trans Am Clin Climatol Assoc. 2011;122:184-97.

15.

Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor.

Lange J, Peterson SM, Takashima JR, Grigoriev Y, Ritchey ML, Shamberger RC, Beckwith JB, Perlman E, Green DM, Breslow NE.

J Urol. 2011 Aug;186(2):378-86. doi: 10.1016/j.juro.2011.03.110. Epub 2011 Jun 17.

16.

Cryptic splice sites and split genes.

Kapustin Y, Chan E, Sarkar R, Wong F, Vorechovsky I, Winston RM, Tatusova T, Dibb NJ.

Nucleic Acids Res. 2011 Aug;39(14):5837-44. doi: 10.1093/nar/gkr203. Epub 2011 Apr 5.

17.

TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.

Sakairi T, Abe Y, Kopp JB.

Nephrol Dial Transplant. 2011 Sep;26(9):2746-52. doi: 10.1093/ndt/gfr061. Epub 2011 Mar 4.

18.

TRPC channel modulation in podocytes-inching toward novel treatments for glomerular disease.

El Hindi S, Reiser J.

Pediatr Nephrol. 2011 Jul;26(7):1057-64. doi: 10.1007/s00467-010-1718-4. Epub 2010 Dec 16. Review.

19.

Pathogenesis and therapy of focal segmental glomerulosclerosis: an update.

Gbadegesin R, Lavin P, Foreman J, Winn M.

Pediatr Nephrol. 2011 Jul;26(7):1001-15. doi: 10.1007/s00467-010-1692-x. Epub 2010 Nov 26. Review.

20.

Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations.

Wasilewska AM, Kuroczycka-Saniutycz E, Zoch-Zwierz W.

Eur J Pediatr. 2011 Mar;170(3):389-91. doi: 10.1007/s00431-010-1278-4. Epub 2010 Sep 17.

Supplemental Content

Support Center